{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:52:25Z","timestamp":1786747945328,"version":"build-2736575974"},"reference-count":210,"publisher":"Elsevier","isbn-type":[{"value":"9780443186677","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.irn.2023.08.003","type":"book-chapter","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:20:58Z","timestamp":1692991258000},"page":"267-305","source":"Crossref","is-referenced-by-count":6,"title":["Chemobrain: An accelerated aging process linking adenosine A2A receptor signaling in cancer survivors"],"prefix":"10.1016","author":[{"given":"Alfredo","family":"Oliveros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Poleschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlev","family":"Boison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hyeon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1074\/jbc.C116.764043","article-title":"The GS protein-coupled A2a adenosine receptor controls T cell help in the germinal center","volume":"292","author":"Abbott","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2023.08.003_bib2","first-page":"1","article-title":"Cancer treatment and survivorship: Facts and figures 2019-2021","volume":"2019","year":"2019","journal-title":"Atlanta: American Cancer Society"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/pon.3545","article-title":"Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking","volume":"23","author":"Ahles","year":"2014","journal-title":"Psycho-oncology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Research and Treatment"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pon.742","article-title":"The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy","volume":"12","author":"Ahles","year":"2003","journal-title":"Psycho-oncology"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102153","article-title":"Targeting the meningeal compartment to resolve chemobrain and neuropathy via nasal delivery of functionalized mitochondria","volume":"11","author":"Alexander","year":"2022","journal-title":"Advanced Healthcare Materials"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib8","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.7150\/thno.53474","article-title":"Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits","volume":"11","author":"Alexander","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13058-020-01368-6","article-title":"Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: A longitudinal study","volume":"22","author":"Alhareeri","year":"2020","journal-title":"Breast Cancer Research: BCR"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","article-title":"Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment","volume":"11","author":"Amidi","year":"2017","journal-title":"Brain Imaging and Behavior"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nature Reviews Endocrinology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpainsymman.2010.04.021","article-title":"Either called \u201cchemobrain\u201d or \u201cchemofog,\u201d the long-term chemotherapy-induced cognitive decline in cancer survivors is real","volume":"41","author":"Argyriou","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/bs.irn.2023.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101854","article-title":"Does oxidative stress shorten telomeres in vivo? A meta-analysis","volume":"85","author":"Armstrong","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13046-022-02511-1","article-title":"Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist","volume":"41","author":"Bai","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib15","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: Historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"issue":"7372","key":"10.1016\/bs.irn.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/annonc\/mdu187","article-title":"Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors","volume":"25","author":"Balmana","year":"2014","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","article-title":"Healthy aging and the blood-brain barrier","volume":"1","author":"Banks","year":"2021","journal-title":"Nature Aging"},{"key":"10.1016\/bs.irn.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"31493","DOI":"10.1038\/srep31493","article-title":"The caffeine-binding adenosine A2a receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function","volume":"6","author":"Batalha","year":"2016","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12015-020-09986-5","article-title":"Immortalization of mesenchymal stromal cells by TERT affects adenosine metabolism and impairs their immunosuppressive capacity","volume":"16","author":"Beckenkamp","year":"2020","journal-title":"Stem Cell Reviews and Reports"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1871520619666190118113201","article-title":"Adenosine analogues as opposite modulators of the cisplatin resistance of ovarian cancer cells","volume":"19","author":"Bednarska-Szczepaniak","year":"2019","journal-title":"Anti-cancer Agents in Medicinal Chemistry"},{"issue":"6265","key":"10.1016\/bs.irn.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science (New York, N. Y.)"},{"issue":"13","key":"10.1016\/bs.irn.2023.08.003_bib23","first-page":"2602","article-title":"The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine","volume":"57","author":"Blay","year":"1997","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","article-title":"Adenosine metabolism: Emerging concepts for cancer therapy","volume":"36","author":"Boison","year":"2019","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/13803395.2019.1623865","article-title":"Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation","volume":"41","author":"Brace","year":"2019","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"Pt 5","key":"10.1016\/bs.irn.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","article-title":"Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias","volume":"127","author":"Calon","year":"2004","journal-title":"Brain"},{"issue":"47","key":"10.1016\/bs.irn.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2023.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112233","article-title":"Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration","volume":"378","author":"Cardoso","year":"2020","journal-title":"Behavioural Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41571-021-00580-3","article-title":"Cancer-related accelerated ageing and biobehavioural modifiers: A framework for research and clinical care","volume":"19","author":"Carroll","year":"2022","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncr.31777","article-title":"Cognitive performance in survivors of breast cancer and markers of biological aging","volume":"125","author":"Carroll","year":"2019","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib31","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1093\/brain\/awz288","article-title":"Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor","volume":"142","author":"Carvalho","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/imm.12053","article-title":"Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8(+) T-cell priming capacity","volume":"138","author":"Challier","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/bs.irn.2023.08.003_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.564965","article-title":"The anti-inflammatory drug aspirin does not protect against chemotherapy-induced memory impairment by paclitaxel in mice","volume":"10","author":"Chang","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1460-9568.2008.06590.x","article-title":"Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades","volume":"29","author":"Chen","year":"2009","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2023.08.003_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","article-title":"Adenosine receptor control of cognition in normal and disease","volume":"119","author":"Chen","year":"2014","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2023.08.003_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109421","article-title":"Striatopallidal adenosine A(2A) receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility","volume":"226","author":"Chen","year":"2023","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signalling"},{"key":"10.1016\/bs.irn.2023.08.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-801022-8.00001-5","article-title":"Adenosine receptor neurobiology: Overview","volume":"119","author":"Chen","year":"2014","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2023.08.003_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbi.2019.04.005","article-title":"Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment","volume":"79","author":"Chiang","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"issue":"85","key":"10.1016\/bs.irn.2023.08.003_bib40","doi-asserted-by":"crossref","first-page":"35581","DOI":"10.18632\/oncotarget.26272","article-title":"Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice","volume":"9","author":"Chiu","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/0008-5472.CAN-16-1817","article-title":"Pifithrin-mu prevents cisplatin-induced chemobrain by preserving neuronal mitochondrial function","volume":"77","author":"Chiu","year":"2017","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12899","article-title":"sFRP3 inhibition improves age-related cellular changes in BubR1 progeroid mice","volume":"18","author":"Cho","year":"2019","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13803390903032537","article-title":"Prechemotherapy alterations in brain function in women with breast cancer","volume":"32","author":"Cimprich","year":"2010","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"19","key":"10.1016\/bs.irn.2023.08.003_bib44","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2014.59.0273","article-title":"Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia","volume":"33","author":"Cole","year":"2015","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/17460441.2018.1534825","article-title":"Targeting adenosine A2A receptor antagonism for treatment of cancer","volume":"13","author":"Congreve","year":"2018","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"Suppl 2","key":"10.1016\/bs.irn.2023.08.003_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5213\/inj.2040436.218","article-title":"Genetic inhibition of sFRP3 prevents glial reactivity in a mouse model of accelerated aging","volume":"24","author":"Corujo-Ramirez","year":"2020","journal-title":"International Neurourology Journal"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib47","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1176\/ajp.2006.163.12.2164","article-title":"Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia","volume":"163","author":"Csernansky","year":"2006","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000250","article-title":"Biology of premature ageing in survivors of cancer","volume":"2","author":"Cupit-Link","year":"2017","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1178025","article-title":"The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27","volume":"5","author":"d\u2019Almeida","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.irn.2023.08.003_bib50","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A(2A) receptors","volume":"7","author":"Da Silva","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/bs.irn.2023.08.003_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib52","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hbm.21102","article-title":"Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer","volume":"32","author":"De Ruiter","year":"2011","journal-title":"Human Brain Mapping"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.irn.2023.08.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112534","article-title":"A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype","volume":"384","author":"Demby","year":"2020","journal-title":"Behavioural Brain Research"},{"issue":"22","key":"10.1016\/bs.irn.2023.08.003_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152924","article-title":"Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects","volume":"132","author":"Dewaeles","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib56","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s11764-020-00969-6","article-title":"Psychological distress and cognition among long-term survivors of adolescent and young adult cancer in the USA","volume":"15","author":"Dewar","year":"2021","journal-title":"Journal of Cancer Survivorship"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00018-022-04492-y","article-title":"Abeta(1-42) peptides blunt the adenosine A(2A) receptor-mediated control of the interplay between P(2)X(7) and P(2)Y(1) receptors mediated calcium responses in astrocytes","volume":"79","author":"Dias","year":"2022","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bandc.2005.05.001","article-title":"The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature","volume":"59","author":"Falleti","year":"2005","journal-title":"Brain and Cognition"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123842","article-title":"Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer\u2019s disease risk factor APOE","volume":"12","author":"Fernandez","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41398-021-01238-5","article-title":"Adenosine A2A receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice","volume":"11","author":"Ferrante","year":"2021","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.003_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109329","article-title":"Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum","volume":"223","author":"Ferre","year":"2023","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib62","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"Alpha-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nature Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib63","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0959-8049(00)00130-1","article-title":"Adenosine acts as an inhibitor of lymphoma cell growth: A major role for the A3 adenosine receptor","volume":"36","author":"Fishman","year":"2000","journal-title":"European Journal of Cancer"},{"key":"10.1016\/bs.irn.2023.08.003_bib64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbi.2021.01.021","article-title":"Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review","volume":"94","author":"George","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","article-title":"Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment","volume":"103","author":"Geraghty","year":"2019","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib66","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/CCO.0000000000000578","article-title":"Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment","volume":"31","author":"Gibson","year":"2019","journal-title":"Current Opinion in Oncology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2023.08.003_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","article-title":"Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment","volume":"176","author":"Gibson","year":"2019","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2023.08.003_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104570","article-title":"Synaptic and memory dysfunction in a beta-amyloid model of early Alzheimer\u2019s disease depends on increased formation of ATP-derived extracellular adenosine","volume":"132","author":"Goncalves","year":"2019","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib70","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: Defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"35","key":"10.1016\/bs.irn.2023.08.003_bib71","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer\u2019s disease","volume":"26","author":"Green","year":"2006","journal-title":"The Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib72","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","article-title":"Cellular senescence at the crossroads of inflammation and Alzheimer's disease","volume":"44","author":"Guerrero","year":"2021","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2023.08.003_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-023-09919-0","article-title":"A(2A) receptor signaling drives cisplatin-mediated hippocampal neurotoxicity and cognitive defects in mice","author":"Gyau","year":"2023","journal-title":"Purinergic Signalling"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/dji137","article-title":"Cancer as a risk factor for long-term cognitive deficits and dementia","volume":"97","author":"Heflin","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib75","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/35104061","article-title":"Dendritic spines: Structure, dynamics and regulation","volume":"2","author":"Hering","year":"2001","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2023.08.003_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2019.04.008","article-title":"Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation","volume":"80","author":"Hoogland","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2023.08.003_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","article-title":"Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer\u2019s disease","volume":"60","author":"Horgusluoglu-Moloch","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2023.08.003_bib78","article-title":"Metformin protects against diabetes-induced cognitive dysfunction by inhibiting mitochondrial fission protein DRP1","volume":"13","author":"Hu","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib79","doi-asserted-by":"crossref","first-page":"17400","DOI":"10.1038\/s41598-018-35919-x","article-title":"Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice","volume":"8","author":"Huo","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/bbrc.2000.2410","article-title":"CD39 modulates IL-1 release from activated endothelial cells","volume":"270","author":"Imai","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib81","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.irn.2023.08.003_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136975","article-title":"Inhibition of NLRP3 alleviated chemotherapy-induced cognitive impairment in rats","volume":"793","author":"Jia","year":"2023","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib83","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2010.01.021","article-title":"Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: Implications for oxidative stress-mediated chemobrain","volume":"166","author":"Joshi","year":"2010","journal-title":"Neuroscience"},{"issue":"25","key":"10.1016\/bs.irn.2023.08.003_bib84","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","article-title":"Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress","volume":"112","author":"Kaster","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2023.08.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108300","article-title":"Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities","volume":"240","author":"Kaur","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib86","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.1900765","article-title":"Adenosine receptor signaling targets both PKA and Epac pathways to polarize dendritic cells to a suppressive phenotype","volume":"203","author":"Kayhan","year":"2019","journal-title":"Journal of Immunology"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib87","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2011.245","article-title":"Prefrontal cortex and executive function impairments in primary breast cancer","volume":"68","author":"Kesler","year":"2011","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2023.08.003_bib88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.dadm.2017.10.002","article-title":"Probability of Alzheimer\u2019s disease in breast cancer survivors based on gray-matter structural network efficiency","volume":"9","author":"Kesler","year":"2017","journal-title":"Alzheimer\u2019s & Dementia (Amst)"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/jimmunol.1700850","article-title":"A2A adenosine receptor gene deletion or synthetic A2A antagonist liberate tumor-reactive CD8(+) T cells from tumor-induced immunosuppression","volume":"201","author":"Kjaergaard","year":"2018","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib90","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Molecular Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib91","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2011.37.0189","article-title":"Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy","volume":"30","author":"Koppelmans","year":"2012","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12609-017-0245-8","article-title":"Mechanisms of neurotoxic symptoms as a result of breast cancer and its treatment: Considerations on the contribution of stress, inflammation, and cellular bioenergetics","volume":"9","author":"Lacourt","year":"2017","journal-title":"Current Breast Cancer Reports"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib94","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"The Oncologist"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib95","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","article-title":"Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors","volume":"30","author":"Lange","year":"2019","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib96","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.2069","article-title":"Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey","volume":"8","author":"Lange","year":"2019","journal-title":"Cancer Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Molecular Psychiatry"},{"issue":"20","key":"10.1016\/bs.irn.2023.08.003_bib98","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1021\/acs.jmedchem.0c00525","article-title":"Discovery of AB680: A potent and selective inhibitor of CD73","volume":"63","author":"Lawson","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2023.08.003_bib99","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.csbj.2015.03.008","article-title":"A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy","volume":"13","author":"Leone","year":"2015","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib100","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1158\/0008-5472.CAN-17-2460","article-title":"Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Research"},{"key":"10.1016\/bs.irn.2023.08.003_bib101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib102","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2017.07.017","article-title":"The corticostriatal adenosine A2A receptor controls maintenance and retrieval of spatial working memory","volume":"83","author":"Li","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.003_bib103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neubiorev.2015.05.007","article-title":"Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging","volume":"55","author":"Lindqvist","year":"2015","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib104","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cns.13190","article-title":"Research progress on adenosine in central nervous system diseases","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: Rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"issue":"15","key":"10.1016\/bs.irn.2023.08.003_bib106","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1158\/0008-5472.CAN-06-0478","article-title":"Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells","volume":"66","author":"Lokshin","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.irn.2023.08.003_bib107","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2016.11.046","article-title":"Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats","volume":"102","author":"Lomeli","year":"2017","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.irn.2023.08.003_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.666710","article-title":"Astrocytes and adenosine A(2A) receptors: Active players in Alzheimer\u2019s disease","volume":"15","author":"Lopes","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib109","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1046\/j.1471-4159.1999.731733.x","article-title":"Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats","volume":"73","author":"Lopes","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2023.08.003_bib110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"Lopez-Otin","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40478-018-0604-3","article-title":"Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment","volume":"6","author":"Ma","year":"2018","journal-title":"Acta Neuropathologica Communications"},{"issue":"22","key":"10.1016\/bs.irn.2023.08.003_bib112","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.4161\/cc.8.22.10026","article-title":"Chemotherapy induces ATP release from tumor cells","volume":"8","author":"Martins","year":"2009","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","article-title":"Molecular mechanisms of ATP secretion during immunogenic cell death","volume":"21","author":"Martins","year":"2014","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.irn.2023.08.003_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neubiorev.2019.05.001","article-title":"Chemotherapy-induced cognitive impairments: A systematic review of the animal literature","volume":"102","author":"Matsos","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/bs.irn.2023.08.003_bib115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ctrv.2017.09.010","article-title":"Chemotherapy-induced cognitive impairments: White matter pathologies","volume":"61","author":"Matsos","year":"2017","journal-title":"Cancer Treatment Reviews"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib116","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-010-1088-4","article-title":"Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study","volume":"123","author":"McDonald","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib117","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4161\/cbt.25643","article-title":"Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth","volume":"14","author":"Mediavilla-Varela","year":"2013","journal-title":"Cancer Biology & Therapy"},{"issue":"24","key":"10.1016\/bs.irn.2023.08.003_bib118","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.2174\/0929867328666211129122550","article-title":"A(2A) adenosine receptor antagonists in neurodegenerative diseases","volume":"29","author":"Merighi","year":"2022","journal-title":"Current Medicinal Chemistry"},{"issue":"22","key":"10.1016\/bs.irn.2023.08.003_bib119","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.223354","article-title":"Mechanically stimulated ATP release from mammalian cells: Systematic review and meta-analysis","volume":"131","author":"Mikolajewicz","year":"2018","journal-title":"Journal of Cell Science"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuron.2011.05.001","article-title":"Adult neurogenesis in the mammalian brain: Significant answers and significant questions","volume":"70","author":"Ming","year":"2011","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10070411","article-title":"Neurodevelopmental consequences of pediatric cancer and its treatment: The role of sleep","volume":"10","author":"Mogavero","year":"2020","journal-title":"Brain Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib122","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ana.21214","article-title":"Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies","volume":"62","author":"Monje","year":"2007","journal-title":"Annals of Neurology"},{"issue":"49","key":"10.1016\/bs.irn.2023.08.003_bib123","article-title":"Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages \u2014 a self amplifying, CD39- and CD73-dependent mechanism for tumor immune escape","volume":"4","author":"Montalban de Barrio","year":"2016","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/bs.irn.2023.08.003_bib124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2017.08.027","article-title":"Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A2A receptors in mice","volume":"126","author":"Moscoso-Castro","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10059-013-0192-9","article-title":"Adenosine signaling in striatal circuits and alcohol use disorders","volume":"36","author":"Nam","year":"2013","journal-title":"Molecules and Cells"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib126","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/cncr.29211","article-title":"Frailty in childhood cancer survivors","volume":"121","author":"Ness","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/bs.irn.2023.08.003_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105915","article-title":"Chemotherapy promotes astrocytic response to Abeta deposition, but not Abeta levels, in a mouse model of amyloid and APOE","volume":"175","author":"Ng","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib128","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012075","article-title":"Cellular mechanisms and treatments for chemobrain: Insight from aging and neurodegenerative diseases","volume":"12","author":"Nguyen","year":"2020","journal-title":"EMBO Molecular Medicine"},{"issue":"13","key":"10.1016\/bs.irn.2023.08.003_bib129","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.15252\/embj.201386907","article-title":"SIRT2 induces the checkpoint kinase BubR1 to increase lifespan","volume":"33","author":"North","year":"2014","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.irn.2023.08.003_bib130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: Adenosine in tumor microenvironment","volume":"7","author":"Ohta","year":"2016","journal-title":"Frontiers in Immunology"},{"issue":"35","key":"10.1016\/bs.irn.2023.08.003_bib131","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"28","key":"10.1016\/bs.irn.2023.08.003_bib132","article-title":"Adenosine A2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function","volume":"119","author":"Oliveros","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib133","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40264-022-01182-3","article-title":"Chemobrain in breast cancer: Mechanisms, clinical manifestations, and potential interventions","volume":"45","author":"Onzi","year":"2022","journal-title":"Drug Safety: An International Journal of Medical Toxicology and Drug Experience"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib134","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2023.08.003_bib135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2017.10.014","article-title":"Istradefylline reduces memory deficits in aging mice with amyloid pathology","volume":"110","author":"Orr","year":"2018","journal-title":"Neurobiology of Disease"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib136","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nn.2341","article-title":"Adenosine A(2A) receptor mediates microglial process retraction","volume":"12","author":"Orr","year":"2009","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib137","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.4049\/jimmunol.0903647","article-title":"Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes","volume":"184","author":"Parish","year":"2010","journal-title":"Journal of Immunology"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib138","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Reports"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib139","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s12276-021-00587-x","article-title":"Hippocampal regenerative medicine: Neurogenic implications for addiction and mental disorders","volume":"53","author":"Peyton","year":"2021","journal-title":"Experimental & Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/BPL-220143","article-title":"Nicotinamide mononucleotide prevents cisplatin-induced mitochondrial defects in cortical neurons derived from human induced pluripotent stem cells","volume":"8","author":"Rashid","year":"2022","journal-title":"Brain Plasticity"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib141","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.175.7.4383","article-title":"Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells","volume":"175","author":"Raskovalova","year":"2005","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib142","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuron.2007.11.023","article-title":"Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses","volume":"57","author":"Rebola","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib143","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2005.01.054","article-title":"Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus","volume":"133","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib144","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jnc.14816","article-title":"Adenosine A1 and A2A receptors differently control synaptic plasticity in the mouse dorsal and ventral hippocampus","volume":"151","author":"Reis","year":"2019","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2023.08.003_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.12.029","volume":"134","author":"Ren","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.irn.2023.08.003_bib146","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","article-title":"Dysregulation of cytokine mediated chemotherapy induced cognitive impairment","volume":"117","author":"Ren","year":"2017","journal-title":"Pharmacological Research: The Official Journal of the Italian Pharmacological Society"},{"key":"10.1016\/bs.irn.2023.08.003_bib147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2018.12.013","article-title":"Purinergic receptors in neurogenic processes","volume":"151","author":"Ribeiro","year":"2019","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.irn.2023.08.003_bib148","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/stem.3421","article-title":"Regulation of hippocampal postnatal and adult neurogenesis by adenosine A2A receptor: Interaction with brain-derived neurotrophic factor","volume":"39","author":"Ribeiro","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/bs.irn.2023.08.003_bib149","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2018.12.001","article-title":"Purinergic signalling and brain development","volume":"95","author":"Rodrigues","year":"2019","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1016\/bs.irn.2023.08.003_bib150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2015.00148","article-title":"ATP as a multi-target danger signal in the brain","volume":"9","author":"Rodrigues","year":"2015","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib151","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1038\/s41467-021-23545-7","article-title":"Restoration of energy homeostasis by SIRT6 extends healthy lifespan","volume":"12","author":"Roichman","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib152","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11033-018-4496-x","article-title":"The non-canonical functions of telomerase: To turn off or not to turn off","volume":"46","author":"Romaniuk","year":"2019","journal-title":"Molecular Biology Reports"},{"issue":"19\u201320","key":"10.1016\/bs.irn.2023.08.003_bib153","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1007\/s00018-021-03925-4","article-title":"Chemotherapy-induced cognitive impairment: Focus on the intersection of oxidative stress and TNFalpha","volume":"78","author":"Rummel","year":"2021","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/bs.irn.2023.08.003_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100047","article-title":"Crosstalk between anticancer drugs and mitochondrial functions","volume":"2","author":"Sahu","year":"2021","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277963","article-title":"GW-2974 and SCH-442416 modulators of tyrosine kinase and adenosine receptors can also stabilize human telomeric G-quadruplex DNA","volume":"17","author":"Salem","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib156","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/dc20-0892","article-title":"Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: The Sydney memory and ageing study","volume":"43","author":"Samaras","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib157","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju057","article-title":"Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer","volume":"106","author":"Sanoff","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.irn.2023.08.003_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136861","article-title":"Mini-review: Aplastic myelin following chemotherapy","volume":"790","author":"Savchuk","year":"2022","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2023.08.003_bib159","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fnhum.2011.00122","article-title":"Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: An FMRI study","volume":"5","author":"Scherling","year":"2011","journal-title":"Frontiers in Human Neuroscience"},{"issue":"16","key":"10.1016\/bs.irn.2023.08.003_bib160","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.18632\/aging.204248","article-title":"New hallmarks of ageing: A 2022 Copenhagen ageing meeting summary","volume":"14","author":"Schmauck-Medina","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/bs.irn.2023.08.003_bib161","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41523-017-0050-6","article-title":"Biomarkers of aging associated with past treatments in breast cancer survivors","volume":"3","author":"Scuric","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"23","key":"10.1016\/bs.irn.2023.08.003_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312697","article-title":"Chemotherapy-induced cognitive impairment and hippocampal neurogenesis: A review of physiological mechanisms and interventions","volume":"22","author":"Sekeres","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib163","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s43587-021-00146-z","article-title":"Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer\u2019s disease models","volume":"1","author":"Shim","year":"2021","journal-title":"Nature Aging"},{"key":"10.1016\/bs.irn.2023.08.003_bib164","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2018.05.024","article-title":"Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"117","author":"Silva","year":"2018","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nbd.2007.04.018","article-title":"Blockade of adenosine A(2A) receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons","volume":"27","author":"Silva","year":"2007","journal-title":"Neurobiology of Disease"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib166","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.neubiorev.2013.04.015","article-title":"Chemobrain: A systematic review of structural and functional neuroimaging studies","volume":"37","author":"Simo","year":"2013","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib167","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-022-01315-w","article-title":"Targeting the A(3) adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice","volume":"10","author":"Singh","year":"2022","journal-title":"Acta Neuropathologica Communications"},{"issue":"19","key":"10.1016\/bs.irn.2023.08.003_bib168","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1158\/1078-0432.CCR-08-0229","article-title":"Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia","volume":"14","author":"Sitkovsky","year":"2008","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib169","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-018-9954-7","article-title":"Development of a human APOE knock-in mouse model for study of cognitive function after cancer chemotherapy","volume":"35","author":"Speidell","year":"2019","journal-title":"Neurotoxicity Research"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib170","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2174\/156802611795347564","article-title":"The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: Pharmacological and clinical aspects","volume":"11","author":"Sperlagh","year":"2011","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2023.08.003_bib171","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(84)90475-8","article-title":"A1 and A2 adenosine receptors modulate acetylcholine release from brain slices","volume":"97","author":"Spignoli","year":"1984","journal-title":"European Journal of Pharmacology"},{"issue":"13","key":"10.1016\/bs.irn.2023.08.003_bib172","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41386-020-00844-z","article-title":"Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications","volume":"45","author":"Squassina","year":"2020","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"39","key":"10.1016\/bs.irn.2023.08.003_bib173","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/onc.2010.292","article-title":"Extracellular adenosine triphosphate and adenosine in cancer","volume":"29","author":"Stagg","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4296","article-title":"Neural correlates of working memory function in pediatric cancer survivors treated with chemotherapy: An fMRI study","volume":"33","author":"Stefancin","year":"2020","journal-title":"NMR in Biomedicine"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.003_bib175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation","volume":"12","author":"Stork","year":"2002","journal-title":"Trends in Cell Biology"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib176","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11302-018-9622-7","article-title":"Adenosine enhances cisplatin sensitivity in human ovarian cancer cells","volume":"14","author":"Sureechatchaiyan","year":"2018","journal-title":"Purinergic Signalling"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib177","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1074\/jbc.M116.768986","article-title":"Phosphorylation of Rap1 by cAMP-dependent protein kinase (PKA) creates a binding site for KSR to sustain ERK activation by cAMP","volume":"292","author":"Takahashi","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"issue":"Suppl 1","key":"10.1016\/bs.irn.2023.08.003_bib178","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5213\/inj.1938036.018","article-title":"Dysfunctional mitochondrial bioenergetics and synaptic degeneration in Alzheimer disease","volume":"23","author":"Tang","year":"2019","journal-title":"International Neurourology Journal"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib179","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/caff.2019.0013","article-title":"Novel players in the aging synapse: Impact on cognition","volume":"9","author":"Temido-Ferreira","year":"2019","journal-title":"Journal of Caffeine and Adenosine Research"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib180","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib181","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jnen\/nlab074","article-title":"Elevated oxidative stress and DNA damage in cortical neurons of chemotherapy patients","volume":"80","author":"Torre","year":"2021","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.003_bib182","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","article-title":"An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline","volume":"11","author":"Trzeciakiewicz","year":"2020","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.003_bib183","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.celrep.2017.07.082","article-title":"The deacetylase HDAC6 mediates endogenous neuritic tau pathology","volume":"20","author":"Tseng","year":"2017","journal-title":"Cell Reports"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.003_bib184","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41409-020-0839-z","article-title":"Premature ageing following allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Uziel","year":"2020","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib185","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1471-4159.1979.tb05236.x","article-title":"Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells","volume":"33","author":"Van Calker","year":"1979","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib186","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.621","article-title":"Brain structure, working memory and response inhibition in childhood leukemia survivors","volume":"7","author":"Van Der Plas","year":"2017","journal-title":"Brain and Behavior"},{"key":"10.1016\/bs.irn.2023.08.003_bib187","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1038\/ncomms11915","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors","volume":"7","author":"Viana Da Silva","year":"2016","journal-title":"Nature Communications"},{"issue":"13","key":"10.1016\/bs.irn.2023.08.003_bib188","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-16-2526","article-title":"Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma","volume":"23","author":"Vogl","year":"2017","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.irn.2023.08.003_bib189","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2021.06.003","article-title":"TFEB protein expression is reduced in aged brains and its overexpression mitigates senescence-associated biomarkers and memory deficits in mice","volume":"106","author":"Wang","year":"2021","journal-title":"Neurobiology of Aging"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030427","article-title":"Cancer treatment-induced accelerated aging in cancer survivors: Biology and assessment","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/bs.irn.2023.08.003_bib191","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.30252","article-title":"Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction","volume":"139","author":"Wardill","year":"2016","journal-title":"International Journal of\u00a0Cancer. Journal International du Cancer"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.003_bib192","first-page":"123","article-title":"Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults","volume":"65","author":"Wefel","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib193","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.20393","article-title":"\u2018Chemobrain\u2019 in breast carcinoma?: A prologue","volume":"101","author":"Wefel","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib194","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","article-title":"Chemotherapy-related cognitive dysfunction","volume":"12","author":"Wefel","year":"2012","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.003_bib195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuro.2008.03.009","article-title":"Chemobrain: A translational challenge for neurotoxicology","volume":"29","author":"Weiss","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/bs.irn.2023.08.003_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114083","article-title":"Neuroprotective effects of hesperidin against methotrexate-induced changes in neurogenesis and oxidative stress in the adult rat","volume":"178","author":"Welbat","year":"2020","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.irn.2023.08.003_bib197","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuropharm.2018.07.007","article-title":"Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model","volume":"139","author":"Wen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2023.08.003_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108939","article-title":"Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate","volume":"206","author":"Wen","year":"2022","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/bs.irn.2023.08.003_bib199","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1200\/JCO.20.02436","article-title":"Biomarkers of cognitive impairment in pediatric cancer survivors","volume":"39","author":"Williams","year":"2021","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"31","key":"10.1016\/bs.irn.2023.08.003_bib200","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.21.00194","article-title":"Physiologic frailty and neurocognitive decline among young-adult childhood cancer survivors: A prospective study from the St Jude lifetime cohort","volume":"39","author":"Williams","year":"2021","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib201","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/2326-6066.CIR-18-0056","article-title":"A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to anti-PD-(L)1 and anti-CTLA-4 in preclinical models","volume":"6","author":"Willingham","year":"2018","journal-title":"Cancer Immunology Research"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.003_bib202","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1007\/s12035-021-02528-1","article-title":"Effects and mechanisms of synaptotagmin-7 in the hippocampus on cognitive impairment in aging mice","volume":"58","author":"Xie","year":"2021","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.003_bib203","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s11064-016-1921-1","article-title":"Inhibition of the Ras\/Raf\/ERK1\/2 signaling pathway restores cultured spinal cord-injured neuronal migration, adhesion, and dendritic spine development","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochemical Research"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib204","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00429-012-0420-7","article-title":"Up-regulation of Ras\/Raf\/ERK1\/2 signaling impairs cultured neuronal cell migration, neurogenesis, synapse formation, and dendritic spine development","volume":"218","author":"Yang","year":"2013","journal-title":"Brain Structure & Function"},{"issue":"Pt 5","key":"10.1016\/bs.irn.2023.08.003_bib205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1242\/jcs.03389","article-title":"Wound-induced ATP release and EGF receptor activation in epithelial cells","volume":"120","author":"Yin","year":"2007","journal-title":"Journal of Cell Science"},{"issue":"13","key":"10.1016\/bs.irn.2023.08.003_bib206","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-20-3290","article-title":"Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments","volume":"81","author":"Yoo","year":"2021","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib207","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.958952","article-title":"Co-blockade of immune checkpoints and adenosine A2A receptor suppresses metastasis","volume":"3","author":"Young","year":"2014","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.003_bib208","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/bs.irn.2023.08.003_bib209","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: A Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.003_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151890","article-title":"Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"}],"container-title":["International Review of Neurobiology","Adenosine A2A Receptor Antagonists"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T22:02:47Z","timestamp":1729980167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774223000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443186677"],"references-count":210,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2023.08.003","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}